Potential role of microRNAs in cardiovascular disease: Are they up to their hype?

Current Cardiology Reviews

Volumn 12, Issue 4, 2016, Pages 304-310

  Duggal, Bhanu ^a,b   Gupta, Manveen K ^a   Naga Prasad, Sathyamangla V ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b SIR J J GROUP OF HOSPITALS   (India)

Author keywords

Cardiovascular disease; Diagnostic biomarkers; MiRNAs

Indexed keywords

CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; NUCLEAR FACTOR; BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAROTID ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; GENE EXPRESSION; HEART FAILURE; HEART INFARCTION; HOMEOSTASIS; HUMAN; HYPERTENSION; INFLAMMATION; MORTALITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; ANTAGONISTS AND INHIBITORS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASES; COMPLICATION; CORONARY ARTERY DISEASE; MACROPHAGE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RUPTURE; VASCULAR ENDOTHELIUM;

BIOMARKERS; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HEART FAILURE; HUMANS; HYPERTENSION; MACROPHAGES; MICRORNAS; MYOCARDIAL INFARCTION; NF-KAPPA B; PLAQUE, ATHEROSCLEROTIC; RUPTURE, SPONTANEOUS;

EID: 84989332560     PISSN: 1573403X     EISSN: 18756557     Source Type: Journal    
DOI: 10.2174/1573403X12666160301120642     Document Type: Review

References (44)

1. Goyal A, Yusuf S. The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res 2006; 124: 235-44.
2. Cathcart P, Lucchesi W, Ottaviani S, et al. Noncoding RNAs and the control of signalling via nuclear receptor regulation in health and disease. Best Pract Res Clin Endocrinol Metab 2015; 29: 529-43.
3. Li M, Zhang J. Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases. Biomed Res Int 2015; 2015: 730535.
4. Economou EK, Oikonomou E, Siasos G, et al. The role of microRNAs in coronary artery disease: From pathophysiology to diagnosis and treatment. Atherosclerosis 2015; 241: 624-33.
5. Yuan Y, Tong L, Wu S. microRNA and NF-kappa B. Adv Exp Med Biol 2015; 887: 157-70.
6. Schober A, Nazari-Jahantigh M, Wei Y, et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med 2014; 20: 368-76.
7. Fang Y, Davies PF. Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium. Arterioscler Thromb Vasc Biol 2012; 32: 979-87.
8. Wu W, Xiao H, Laguna-Fernandez A, et al. Flow-Dependent Regulation of Kruppel-Like Factor 2 Is Mediated by MicroRNA-92a. Circulation 2011; 124: 633-41.
9. Nazari-Jahantigh M, Egea V, Schober A, Weber C. MicroRNAspecific regulatory mechanisms in atherosclerosis. J Mol Cell Cardiol 2015; 89: 35-41.
10. Hartmann P, Schober A, Weber C. Chemokines and microRNAs in atherosclerosis. Cell Mol Life Sci 2015; 72: 3253-66.
11. Wang Y, Mao G, Lv Y, Huang Q, Wang G. MicroRNA-181b stimulates inflammation via the nuclear factor-kappaB signaling pathway. Exp Ther Med 2015; 10: 1584-90.
12. Li X, Cao G. Potential role of microRNA-181b on atherosclerosis. Zhonghua Xin Xue Guan Bing Za Zhi 2015; 43: 516-20.
13. Dai Y, Condorelli G, Mehta JL. Scavenger receptors and noncoding RNAs: relevance in atherogenesis. Cardiovasc Res 2016; 109: 24-33.
14. Martino F, Carlomosti F, Avitabile D, et al. Circulating miR-33a and miR-33b are up-regulated in familial hypercholesterolaemia in paediatric age. Clin Sci (Lond) 2015; 129: 963-72.
15. Akhtar S, Hartmann P, Karshovska E, et al. Endothelial Hypoxia-Inducible Factor-1alpha Promotes Atherosclerosis and Monocyte Recruitment by Upregulating MicroRNA-19a. Hypertension 2015; 66: 1220-6.
16. Rotllan N, Fernandez-Hernando C. MicroRNA Regulation of Cholesterol Metabolism. Cholesterol 2012; 2012: 847-9.
17. Fernandez-Hernando C, Suarez Y, Rayner KJ, Moore KJ. MicroRNAs in lipid metabolism. Curr Opin Lipidol 2011; 22: 86-92.
18. Jopling C. Liver-specific microRNA-122: Biogenesis and function. RNA Biol 2012; 9: 137-42.
19. Gholamin S, Pasdar A, Khorrami MS, et al. The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment. Curr Pharm Des 2015; 22: 397-403.
20. Liu X, Fan Z, Zhao T, et al. Plasma miR-1, miR-208, miR-499 as potential predictive biomarkers for acute myocardial infarction: An independent study of Han population. Exp Gerontol 2015; 72: 230-8.
21. Wang J, Chen J, Sen S. MicroRNA as Biomarkers and Diagnostics. J Cell Physiol 2016; 231: 25-30.
22. Wang GK, Zhu JQ, Zhang JT, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010; 31: 659-66.
23. Jaguszewski M, Osipova J, Ghadri JR, et al. A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction. Eur Heart J 2014; 35: 999-1006.
24. Hoekstra M, van der Lans CA, Halvorsen B, et al. The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem Biophys Res Commun 2010; 394: 792-7.
25. Marques FZ, Charchar FJ. microRNAs in Essential Hypertension and Blood Pressure Regulation. Adv Exp Med Biol 2015; 888: 215-35.
26. Rangrez AY, Massy ZA, Metzinger-Le Meuth V, Metzinger L. miR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells. Circ Cardiovasc Genet 2011; 4: 197-205.
27. Li S, Zhu J, Zhang W, et al. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation 2011; 124: 175-84.
28. Tijsen AJ, Pinto YM, Creemers EE. Non-cardiomyocyte microRNAs in heart failure. Cardiovasc Res 2012; 93: 573-82.
29. Zampetaki A, Kiechl S, Drozdov I, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010; 107: 810-7.
30. Deiuliis JA. MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics. Int J Obes (Lond) 2016; 40(1): 88-101.
31. Nouraee N, Mowla SJ. miRNA therapeutics in cardiovascular diseases: promises and problems. Front Genet 2015; 6: 232.
32. Kumar S, Kim CW, Simmons RD, Jo H. Role of flow-sensitive microRNAs in endothelial dysfunction and atherosclerosis: mechanosensitive athero-miRs. Arterioscler Thromb Vasc Biol 2014; 34: 2206-16.
33. Salloum FN, Yin C, Kukreja RC. Role of microRNAs in cardiac preconditioning. J Cardiovasc Pharmacol 2010; 56: 581-8.
34. Gurianova V, Stroy D, Ciccocioppo R, et al. Stress response factors as hub-regulators of microRNA biogenesis: implication to the diseased heart. Cell Biochem Funct 2015. [Epub ahead of print]
35. Hao L, Wang XG, Cheng JD, et al. The up-regulation of endothelin-1 and down-regulation of miRNA-125a-5p, -155, and -199a/b-3p in human atherosclerotic coronary artery. Cardiovasc Pathol 2014; 23: 217-23.
36. Tang Y, Zheng J, Sun Y, Wu Z, Liu Z, Huang G. MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int Heart J 2009; 50: 377-87.
37. Xu C, Lu Y, Pan Z, et al. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 2007; 120: 3045-52.
38. Sabatel C, Malvaux L, Bovy N, et al. MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells. PLoS One 2011; 6: e16979.
39. Arnold N, Koppula PR, Gul R, Luck C, Pulakat L. Regulation of cardiac expression of the diabetic marker microRNA miR-29. PLoS One 2014; 9: e103284.
40. Kim HW, Haider HK, Jiang S, Ashraf M. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J Biol Chem 2009; 284: 33161-8.
41. Madrigal-Matute J, Rotllan N, Aranda JF, Fernandez-Hernando C. MicroRNAs and atherosclerosis. Curr Atheroscler Rep 2013; 15: 322-013-0322-z.
42. Urbich C, Kuehbacher A, Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 2008; 79: 581-8.
43. Rangrez AY, Massy ZA, Metzinger-Le Meuth V, Metzinger L. miR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells. Circ Cardiovasc Genet 2011; 4: 197-205.
44. Dong S, Xiong W, Yuan J, Li J, Liu J, Xu X. MiRNA-146a regulates the maturation and differentiation of vascular smooth muscle cells by targeting NF-kappaB expression. Mol Med Rep 2013; 8: 407-12.